Literature DB >> 1311336

In vitro transcription and translation of group B rotavirus strain IDIR gene 8 and immunoprecipitation by human sera.

J J Eiden1, S B Wee, S L Vonderfecht.   

Abstract

Group B rotaviruses (GBRs) are associated with episodes of acute diarrhea in humans and a variety of animal species. To date, these agents have not been well adapted to growth in tissue culture, and evaluation of human sera for antibodies directed against GBRs has been hindered by the inability to obtain standardized and highly purified preparations of GBR antigens. In order to evaluate the reactivities of antisera with a highly specific antigen, we prepared a full-length cDNA clone of gene 8 of the IDIR strain of GBR. This clone was transcribed with T7 RNA polymerase, and the resulting RNA was translated in vitro with rabbit erythrocyte lysates. The polypeptide expressed from IDIR gene 8 was specifically precipitated by antibody directed against IDIR but not by antibody directed against ADRV (adult diarrhea rotavirus) or bovine strains of GBR. Subsequent immunoprecipitation reactions confirmed the presence of anti-IDIR antibodies among the U.S. population. Of 129 human serum specimens, 3 specifically immunoprecipitated the IDIR gene 8 polypeptide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311336      PMCID: PMC265074          DOI: 10.1128/jcm.30.2.440-443.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Identification of a group-reactive epitope of group B rotaviruses recognized by monoclonal antibody and application to the development of a sensitive immunoassay for viral characterization.

Authors:  R Yolken; S B Wee; J Eiden; J Kinney; S Vonderfecht
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Preparation of capped RNA transcripts using T7 RNA polymerase.

Authors:  D A Nielsen; D J Shapiro
Journal:  Nucleic Acids Res       Date:  1986-07-25       Impact factor: 16.971

4.  The commonest rotaviruses from neonatal lamb diarrhoea in England and Wales have atypical electropherotypes.

Authors:  D Chasey; J Banks
Journal:  Vet Rec       Date:  1984-09-29       Impact factor: 2.695

5.  Simple, efficient in vitro synthesis of capped RNA useful for direct expression of cloned eukaryotic genes.

Authors:  R Contreras; H Cheroutre; W Degrave; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

6.  Identification of a bovine enteric syncytial virus as a nongroup A rotavirus.

Authors:  S L Vonderfecht; J J Eiden; A Torres; R L Miskuff; C A Mebus; R H Yolken
Journal:  Am J Vet Res       Date:  1986-09       Impact factor: 1.156

7.  Removal of inhibitory substances from human fecal specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain reactions.

Authors:  J Wilde; J Eiden; R Yolken
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

8.  Evidence that a novel rotavirus-like agent of rats can cause gastroenteritis in man.

Authors:  J Eiden; S Vonderfecht; R H Yolken
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

9.  Enzyme immunoassay inhibition assay for the detection of rat rotavirus-like agent in intestinal and fecal specimens obtained from diarrheic rats and humans.

Authors:  S L Vonderfecht; R L Miskuff; J J Eiden; R H Yolken
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

10.  Evidence for trans splicing in trypanosomes.

Authors:  R E Sutton; J C Boothroyd
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

View more
  1 in total

1.  Serum antibody response to recombinant major inner capsid protein following human infection with group B rotavirus.

Authors:  J J Eiden; A Mouzinho; D A Lindsay; R I Glass; Z Y Fang; J L Taylor
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.